Remedy, a gaming company, has reported that sales of its newest game have continued at a high average price. The company is already looking ahead to future projects and the possibility of self-publishing games. In a recent business overview, Remedy reported an operating loss of EUR 2.1 million in the quarter, with a turnover of EUR 10.8 million. This was better than analysts’ expectations, who had forecasted a larger loss and lower turnover.
The company’s recent focus has been on developing multiple projects, with the most recent game, Alan Wake 2, released at the end of last year. Sales of Alan Wake 2 have been strong, covering a significant part of development and marketing costs. The company is also working on additional downloadable content for the game. Remedy is optimistic about its outlook for the year, expecting increased turnover and improved operating profit.
Remedy is also working on other projects, including Codename Condor and Control 2. The company expects these games to contribute positively to its future results. Development fees and royalties from past games like Control and Alan Wake Remastered have helped to boost the company’s revenue. Remedy is confident in its ability to continue to grow and succeed in the gaming industry.
The company is also exploring self-publishing options for its games, which could impact its future growth. Remedy is committed to delivering engaging and unique gaming experiences to its audience
